MLH1 and breast carcinoma: Regarding the potential role of the MLH1 polymorphism (Ile219Val), it was not associated with breast cancer risk in this study, which is consistent with a previous work conducted by Lee et al. [32] that also reports a null association for breast cancer in Korean women (872 cases and 671 controls).